Tassneem Awad Hajali

Dr. Tassneem Awad Hajali

Clinical science department, Sulaiman Al Rajhi Colleges, Al Bukayrīyah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Tassneem Awad HajaliTassneem Awad Hajali
Tassneem Awad Hajali
IAIshag Adam
Ishag Adam
Retinol-binding protein 4 (RBP4) is claimed to be associated with the development of preeclampsia, yet the reports are inconclusive. This systematic review and meta-analysis aimed to assess the association between RBP4 levels and preeclampsia. The PubMed, Google Scholar and ScienceDirect databases were searched for studies that investigated RBP4 levels in preeclampsia patients and compared them with normal controls. The meta-analysis was conducted by calculating the standardized mean difference (SMD) of RBP4 between cases and controls. The meta package with the R software was used to perform all statistical analysis. A total of 13 studies, comprising 569 cases and 1411 controls, met the inclusion criteria and were thus included in the meta-analysis. According to the random effect model, the SMD of RBP4 was significantly higher in women with preeclampsia compared with normal controls [SMD of RBP4: 0.55 ng/mL; 95% CI (0.06; 1.05); p = 0.028; I2 = 89%]. Likewise, the stratified meta-analysis showed the same pattern in the studies which measured RBP4 levels in the third trimester, as well as in the studies that investigated severe preeclampsia. Meta-regression did not identify any factor that significantly affected the overall estimate. There was no evidence of reporting bias (Egger’s test; t = 0.43; p = 0.587). This meta-analysis with high heterogeneity showed that higher levels of RBP4 were associated with preeclampsia risk. More longitudinal studies spanning the three trimester periods are needed to clarify the association of RBP4 and its dynamics in preeclampsia cases throughout pregnancy.

11 February 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
IOIslamia Ibrahim Ahmed Omer
Islamia Ibrahim Ahmed Omer
EAEman Adam
Eman Adam
Tassneem Awad HajaliTassneem Awad Hajali
Tassneem Awad Hajali
NANouralsalhin A. Alaagib
Nouralsalhin A. Alaagib
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Background: Migraine is a neurovascular disease; its pathogenesis has been linked to higher levels of homocysteine (Hcy) and/or deficiencies in vitamins (vitamin B12 and folate). However, previously published studies remained inconclusive. Therefore, the aim of this study is to review the literature to update the current evidence and clarify the association between Hcy, vitamin B12, folate and migraine in adult and pediatric patients. Methods: We searched the databases PubMed, ScienceDirect, Google Scholar, and the Cochrane Library for articles that investigated levels of Hcy, B12, and folate in association with migraine headaches, since inception through December 2025. The package “meta” in R software was used to calculate the standardized mean difference (SMD) of Hcy, B12 and folate in cases of migraine and compared with non-migraine controls. Results: A total of 17 studies (15 case–control and 2 cross-sectional) investigated the levels of Hcy, encompassing 1549 cases of migraine and 1824 non-migraine controls. The random effect model showed a significantly higher SMD for Hcy in migraine cases compared with non-migraine controls [SMD = 0.48, 95% CI (0.12; 0.83); p < 0.01; I2 = 91.0%]. Stratification analysis showed the same trends in a group of studies that was conducted in European countries [SMD = 0.29; 95% CI (0.04; 0.54); p = 0.02; I2 = 87.0%] and group of studies that used analytical methods other than immunoassays [SMD = 0.28; 95% CI (0.08; 0.49); p < 0.001; I2 = 84.0%]. Meta-regression results showed that only the year of publication had a significant positive effect [estimation coefficient = 0.087; p = 0.017]. Serum levels of vitamin B12 [16 studies included 1330 cases vs. 1533 controls, SMD = −0.36, 95% CI (−0.62; −0.10); p < 0.01; I2 = 92.1%] and folate [10 studies included with 793 cases vs. 1011 controls, SMD = −0.25 [−0.47; −0.04], p = 0.02; I2 = 77.3%] were found to be significantly lower in migraine cases compared with non-migraine controls, respectively. Conclusions: Adult and pediatric patients with migraine had elevated Hcy levels and lower vitamin B12 and folate levels. Clinicians may check and correct for Hcy, vitamin B12, and folate levels as prophylactic and therapeutic interventions for migraine. Further studies with a longitudinal design are needed to establish a causal relationship.

6 April 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
EAEman Adam
Eman Adam
SHSara Z. Hamdan
Sara Z. Hamdan
Tassneem Awad HajaliTassneem Awad Hajali
Tassneem Awad Hajali
MYMohamad Yosof
Mohamad Yosof
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Background/Objectives: Magnesium is an intracellular cation that plays important roles in metabolism and insulin signaling. The evidence of association between magnesium levels and diabetic retinopathy is limited by small study effects. Therefore, this systematic review and meta-analysis aim to update the current evidence. Methods: A comprehensive search of PubMed, ScienceDirect, Google Scholar, and Scopus was conducted from database inception to January 2026 to identify studies examining magnesium levels and diabetic retinopathy. The pooled standardized mean difference in magnesium levels between type 2 diabetic patients with retinopathy and those without retinopathy was estimated using the “meta” package in R software. Results: We included seventeen studies which assessed magnesium levels in 1100 patients with diabetic retinopathy and 1132 diabetic controls without retinopathy. The random-effects model indicated significantly lower magnesium levels in patients with diabetic retinopathy compared to diabetic controls [SMD = −1.19, 95% CI (−1.68; −0.70); p < 0.0001; I2 = 95%]. Sensitivity analysis retained all studies, and no evidence of publication bias was detected. Subgroup analyses demonstrated consistent findings across geographic regions (Asian versus non-Asian), study designs (case–control versus cross-sectional), and magnesium assay methods except enzymatic method. Meta-regression analysis revealed that year of publication (coefficient = 0.061; p = 0.009) and non-Asian studies (coefficient = 2.376; p = 0.001) were positively associated with the pooled effect size, while the NOS quality score was inversely associated (coefficient = −0.709; p = 0.035). The magnesium levels were significantly lower in patients with proliferative diabetic retinopathy compared with those with non-proliferative diabetic retinopathy using a fixed effect model [SMD = −1.41, (95% CI: −1.83; −1.00); p < 0.01; I2 = 32%; Cochran’s Q statistic (Q = 1.46, p < 0.23)]. The certainty of the generated evidence is rated as low certainty. Conclusions: This systematic review and meta-analysis conclude that magnesium levels are significantly lower in patients with diabetic retinopathy than in diabetic controls without retinopathy. A potential association between hypomagnesemia and the development of diabetic retinopathy in individuals with type 2 diabetes is suggested; therefore, the clinician may check and adjust magnesium levels in patients with type 2 diabetes mellitus.

Verified
Journal Article
Open access
PDF file
Tassneem Awad HajaliTassneem Awad Hajali
Tassneem Awad Hajali
MMMuna Ismail Elmisbah Mekki
Muna Ismail Elmisbah Mekki
NANouralsalhin A. Alaagib
Nouralsalhin A. Alaagib
IOIslamia Ibrahim Ahmed Omer
Islamia Ibrahim Ahmed Omer
RYRabab Mahadi Yahia
Rabab Mahadi Yahia
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Background/Objectives: Severe Plasmodium falciparum malaria remains a leading cause of childhood morbidity and mortality in sub-Saharan Africa. The clinical outcome is largely driven by the balance between pro-inflammatory and anti-inflammatory cytokines. However, immunological data from Sudanese children remain limited and the diagnostic utility of cytokine biomarkers has not been formally evaluated in this population. Therefore, this study aims to compare plasma levels of IFN-γ and IL-10 among Sudanese children with severe malaria (SM), uncomplicated malaria (UM) and healthy controls (HC) and to evaluate their diagnostic accuracy using in differentiating SM from UM cases. Methods: A hospital-based case–control study was conducted at Mohamed Elamin Hamid Pediatric Hospital, Omdurman, Sudan. The study enrolled 105 children (aged 3 months to 16 years) divided into three age- and sex-matched groups (n = 35 per group): SM, UM and HC. Plasma cytokines IFN-γ and IL-10 were measured by ELISA. Results: The anthropometric measurements did not differ significantly across the groups. SM was significantly associated with lower hemoglobin and markedly reduced platelet counts. Both IFN-γ and IL-10 were significantly elevated in SM versus UM and HC (p < 0.001). A strong positive correlation was observed between IFN-γ and IL-10 (rho = 0.688, p < 0.001) in malaria patients. Additionally, a significant correlation was observed between IL-10 and platelet count (rho = −0.338, p = 0.009). Both IL-10 (AUC = 0.0.720) and IFN-γ (AUC = 0.687) demonstrated moderate diagnostic performance in discriminating between SM vs. UM. Conclusions: Elevated levels of IFN-γ and IL-10 strongly associated with severe P. falciparum malaria in Sudanese children. Measuring IL-10 and IFN-γ at the time of presentation may differentiate between SM and UM cases. Further studies are needed.

Verified
Journal Article
Open access
PDF file
Tassneem Awad HajaliTassneem Awad Hajali
Tassneem Awad Hajali
IOIslamia Ibrahim Ahmed Omer
Islamia Ibrahim Ahmed Omer
MYMohamad Yosof
Mohamad Yosof
Hamdan Zaki HamdanHamdan Zaki Hamdan
Hamdan Zaki Hamdan
Pathogenic variants in the thyroid-stimulating hormone receptor gene (TSHR) contribute to a wide spectrum of thyroid dysfunctions, ranging from congenital hypothyroidism to thyrotropin resistance. With the advancement of bioinformatics algorithms for variant effect prediction, assessing the pathogenic potential of variants has become increasingly important. This study aimed to investigate the pathogenic effects of TSHR variants classified as variants of uncertain significance (VUSs) in the gnomAD v4.1.0 database. TSHR variants listed in gnomAD v4.1.0 were retrieved and filtered to select missense VUSs based on ClinVar classifications. Multiple bioinformatics tools were used to assess the secondary and three-dimensional structures of the TSHR, as well as protein stability, evolutionary conservation, and molecular dynamics simulations. A total of 2760 TSHR variants were found in gnomAD v4.1.0, including 75 frameshifts, 80 splice-sites, 265 in the 3′ and 5′ untranslated regions, 422 synonymous, 892 others, and 1026 missense variants. Among these, 68 missense VUSs were identified and selected for bioinformatics analysis. Three variants (p.Cys29Trp, p.Leu57Pro, and p.Phe97Ser) were consistently predicted to be pathogenic by all the bioinformatics tools used. All three variants were located within the leucin-rich repeat domain extracellular region of the TSHR and within a highly conserved region across species. Molecular dynamics simulations for mutant proteins (p.Cys29Trp, p.Leu57Pro, and p.Phe97Ser) reveal structural instability in comparison to the wild protein. Comprehensive bioinformatics analysis revealed that three TSHR missense VUSs exhibited pathogenic potential. These variants may contribute to thyroid dysfunction by affecting the receptor’s structural and signalling integrity.